Lineage relationship of prostate cancer cell types based on gene expression

BMC Medical Genomics

Volumn 4, Issue , 2011, Pages

  Pascal, Laura E ^a,b,c   Vêncio, Ricardo Zn ^d   Vessella, Robert L ^a   Ware, Carol B ^b   Vêncio, Eneida F ^e   Denyer, Gareth ^f   Liu, Alvin Y ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^f UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; TRANSCRIPTOME; ABC TRANSPORTER; ABCG2 PROTEIN, HUMAN; CD133 ANTIGEN; GLYCOPROTEIN; HERMES ANTIGEN; LEUKOCYTE ANTIGEN; PEPTIDE; TUMOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER STEM CELL; CELL ISOLATION; CELL LINEAGE; CELL POPULATION; CELL TYPE; CONTROLLED STUDY; DNA MICROARRAY; EMBRYONAL CARCINOMA; EMBRYONIC STEM CELL; GENE EXPRESSION; GLEASON SCORE; MALE; METASTASIS; MOLECULAR PHYLOGENY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; TUMOR XENOGRAFT; ANIMAL; DRUG SCREENING; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PHENOTYPE; PRINCIPAL COMPONENT ANALYSIS; PROSTATE TUMOR; TUMOR CELL LINE;

MUS;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD44; ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE, TUMOR; CELL LINEAGE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; HUMANS; MALE; MICE; NEOPLASM PROTEINS; NEOPLASTIC STEM CELLS; PEPTIDES; PHENOTYPE; PRINCIPAL COMPONENT ANALYSIS; PROSTATIC NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79956203121     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-4-46     Document Type: Article

References (49)

1. Prospective identification of tumorigenic breast cancer cells. M Al-Hajj MS Wicha A Benito-Hernandez SJ Morrison MF Clarke, Proc Natl Acad Sci USA 2003 100 7 3983 3988 10.1073/pnas.0530291100 12629218 (Pubitemid 36418143)
2. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. D Bonnet JE Dick, Nature Medicine 1997 3 7 730 737 10.1038/nm0797-730 9212098 (Pubitemid 27298715)
3. Prospective identification of tumorigenic prostate cancer stem cells. AT Collins PA Berry C Hyde MJ Stower NJ Maitland, Cancer Res 2005 65 23 10946 10951 10.1158/0008-5472.CAN-05-2018 16322242 (Pubitemid 41713363)
4. Cancer statistics, 2000. RT Greenlee T Murray S Bolden PA Wingo, CA: A Cancer Journal for Clinicians 2000 50 1 7 33 10.3322/canjclin.50.1.7 (Pubitemid 30072093)
5. Normal and abnormal development of the male urogenital tract. Role of androgens, mesenchymal-epithelial interactions, and growth factors. GR Cunha ET Alarid T Turner AA Donjacour EL Boutin BA Foster, Journal of Andrology 1992 13 6 465 475 1293128
6. Mesenchymal reprogramming of adult human epithelial differentiation. S Aboseif A El-Sakka P Young G Cunha, Differentiation 1999 65 2 113 118 10.1046/j.1432-0436.1999.6520113.x 10550544 (Pubitemid 29500315)
7. + prostate tumor-associated stromal cells involves potential organ-specific genes. LE Pascal YA Goo RZ Vencio LS Page AA Chambers ES Liebeskind TK Takayama LD True AY Liu, BMC Cancer 2009 9 317 10.1186/1471-2407-9-317 19737398
8. Gene expression relationship between prostate cancer cells of Gleason 3, 4 and normal epithelial cells as revealed by cell type-specific transcriptomes. LE Pascal RZ Vencio LS Page ES Liebeskind CP Shadle P Troisch B Marzolf LD True LE Hood AY Liu, BMC Cancer 2009 9 452 10.1186/1471-2407-9-452 20021671
9. An update of the Gleason grading system. JI Epstein, J Urol 2010 183 2 433 440 10.1016/j.juro.2009.10.046 20006878
10. Cell lines used in prostate cancer research: a compendium of old and new lines - part 1. RE Sobel MD Sadar, J Urol 2005 173 2 342 359 10.1097/01.ju.0000141580.30910.57 15643172
11. LuCaP 35: a new model of prostate cancer progression to androgen independence. E Corey JE Quinn KR Buhler PS Nelson JA Macoska LD True RL Vessella, Prostate 2003 55 4 239 246 10.1002/pros.10198 12712403 (Pubitemid 36618182)
12. A neuroendocrine/small cell prostate carcinoma xenograft-LuCaP 49. LD True K Buhler J Quinn E Williams PS Nelson N Clegg JA Macoska T Norwood A Liu W Ellis,, et al. Am J Pathol 2002 161 2 705 715 10.1016/S0002-9440(10)64226-5 12163395 (Pubitemid 36142179)
13. Retinoic acid-induced differentiation of the developmentally pluripotent human germ cell tumor-derived cell line, NCCIT. I Damjanov B Horvat Z Gibas, Lab Invest 1993 68 2 220 232 7680083 (Pubitemid 23084295)
14. A comparison of NIH-approved human ESC lines. CB Ware AM Nelson CA Blau, Stem cells 2006 24 12 2677 2684 10.1634/stemcells.2005-0452 16916927 (Pubitemid 46053005)
15. Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. JM Sperger X Chen JS Draper JE Antosiewicz CH Chon SB Jones JD Brooks PW Andrews PO Brown JA Thomson, Proc Natl Acad Sci USA 2003 100 23 13350 13355 10.1073/pnas.2235735100 14595015 (Pubitemid 37444745)
16. Temporal expression profiling of the effects of secreted factors from prostate stromal cells on embryonal carcinoma stem cells. LE Pascal RZ Vencio YA Goo LS Page CP Shadle AY Liu, Prostate 2009 69 12 1353 1365 10.1002/pros.20982 19455603
17. Transcriptomes of human prostate cells. AJ Oudes DS Campbell CM Sorensen LS Walashek LD True AY Liu, BMC Genomics 2006 7 92 10.1186/1471-2164-7-92 16638148
18. Molecular and cellular characterization of ABCG2 in the prostate. LE Pascal AJ Oudes TW Petersen YA Goo LS Walashek LD True AY Liu, BMC Urol 2007 7 6 10.1186/1471-2490-7-6 17425799
19. The urologic epithelial stem cell database (UESC) - a web tool for cell type-specific gene expression and immunohistochemistry images of the prostate and bladder. LE Pascal EW Deutsch DS Campbell M Korb LD True AY Liu, BMC Urol 2007 7 19 10.1186/1471-2490-7-19 18072977
20. Correlation of mRNA and protein levels: cell type-specific gene expression of cluster designation antigens in the prostate. LE Pascal LD True DS Campbell EW Deutsch M Risk IM Coleman LJ Eichner PS Nelson AY Liu, BMC Genomics 2008 9 246 10.1186/1471-2164-9-246 18501003
21. Heterogeneity of molecular targets on clonal cancer lines derived from a novel hormone-refractory prostate cancer tumor system. SJ Freedland AJ Pantuck SH Paik A Zisman TG Graeber D Eisenberg WH McBride D Nguyen CL Tso AS Belldegrun, Prostate 2003 55 4 299 307 10.1002/pros.10226 12712409 (Pubitemid 36618188)
22. Loss of CD10 (neutral endopeptidase) is a frequent and early event in human prostate cancer. SJ Freedland DB Seligson AY Liu AJ Pantuck SH Paik S Horvath JA Wieder A Zisman D Nguyen CL Tso,, et al. Prostate 2003 55 1 71 80 10.1002/pros.10202 12640663 (Pubitemid 36397747)
23. Application of Affymetrix array and Massively Parallel Signature Sequencing for identification of genes involved in prostate cancer progression. AJ Oudes JC Roach LS Walashek LJ Eichner LD True RL Vessella AY Liu, BMC Cancer 2005 5 86 10.1186/1471-2407-5-86 16042785
24. Characterization of a novel androgen-sensitive, prostate-specific antigen-producing prostatic carcinoma xenograft: LuCaP 23. WJ Ellis RL Vessella KR Buhler F Bladou LD True SA Bigler D Curtis PH Lange, Clin Cancer Res 1996 2 6 1039 1048 9816265
25. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. RA Irizarry B Hobbs F Collin YD Beazer-Barclay KJ Antonellis U Scherf TP Speed, Biostatistics 2003 4 2 249 264 10.1093/biostatistics/4.2.249 12925520
26. SBEAMS-Microarray: database software supporting genomic expression analyses for systems biology. B Marzolf EW Deutsch P Moss D Campbell MH Johnson T Galitski, BMC Bioinformatics 2006 7 286 10.1186/1471-2105-7-286 16756676
27. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model. H Bonkhoff K Remberger, Prostate 1996 28 2 98 106 10.1002/(SICI)1097-0045(199602)28:2<98::AID-PROS43.0.CO;2-J 8604398 (Pubitemid 26066247)
28. CD9 is associated with leukemia inhibitory factor-mediated maintenance of embryonic stem cells. M Oka K Tagoku TL Russell Y Nakano T Hamazaki EM Meyer T Yokota N Terada, Mol Biol Cell 2002 13 4 1274 1281 10.1091/mbc.02-01-0600 11950938 (Pubitemid 34309622)
29. Clinical-scale expansion of a mixed population of bone-marrow-derived stem and progenitor cells for potential use in bone-tissue regeneration. JE Dennis K Esterly A Awadallah CR Parrish GM Poynter KL Goltry, Stem cells 2007 25 10 2575 2582 10.1634/stemcells.2007-0204 17585167 (Pubitemid 47582750)
30. Characterization of prostate cell types by CD cell surface molecules. AY Liu LD True, Am J Pathol 2002 160 1 37 43 10.1016/S0002-9440(10)64346-5 11786396 (Pubitemid 34052263)
31. Heterogeneity in primary and metastatic prostate cancer as defined by cell surface CD profile. AY Liu MP Roudier LD True, Am J Pathol 2004 165 5 1543 1556 10.1016/S0002-9440(10)63412-8 15509525 (Pubitemid 39435154)
32. Lineage relationship between LNCaP and LNCaP-derived prostate cancer cell lines. AY Liu KD Brubaker YA Goo JE Quinn S Kral CM Sorensen RL Vessella AS Belldegrun LE Hood, Prostate 2004 60 2 98 108 10.1002/pros.20031 15162376 (Pubitemid 38758575)
33. Generation of a prostate from a single adult stem cell. KG Leong BE Wang L Johnson WQ Gao, Nature 2008 456 7223 804 808 10.1038/nature07427 18946470
34. Integrative molecular concept modeling of prostate cancer progression. SA Tomlins R Mehra DR Rhodes X Cao L Wang SM Dhanasekaran S Kalyana-Sundaram JT Wei MA Rubin KJ Pienta,, et al. Nat Genet 2007 39 1 41 51 10.1038/ng1935 17173048 (Pubitemid 46026500)
35. Evaluation of the frequency of putative prostate cancer stem cells in primary and metastatic prostate cancer. CL Eaton M Colombel G van der Pluijm M Cecchini A Wetterwald J Lippitt I Rehman F Hamdy G Thalman, Prostate 2010 70 8 875 882 20127735
36. A luminal epithelial stem cell that is a cell of origin for prostate cancer. X Wang M Kruithof-de Julio KD Economides D Walker H Yu MV Halili YP Hu SM Price C Abate-Shen MM Shen, Nature 2009 461 7263 495 500 10.1038/nature08361 19741607
37. Basal epithelial stem cells are efficient targets for prostate cancer initiation. DA Lawson Y Zong S Memarzadeh L Xin J Huang ON Witte, Proc Natl Acad Sci USA 2010 107 6 2610 2615 10.1073/pnas.0913873107 20133806
38. In vitro propagation and characterization of neoplastic stem/progenitor-like cells from human prostate cancer tissue. N Guzman-Ramirez M Voller A Wetterwald M Germann NA Cross CA Rentsch J Schalken GN Thalmann MG Cecchini, Prostate 2009 69 15 1683 1693 10.1002/pros.21018 19644960
39. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. SA Tomlins DR Rhodes S Perner SM Dhanasekaran R Mehra XW Sun S Varambally X Cao J Tchinda R Kuefer,, et al. Science 2005 310 5748 644 648 10.1126/science.1117679 16254181 (Pubitemid 41528150)
40. The TRAMP mouse as a model for prostate cancer. AA Hurwitz BA Foster JP Allison NM Greenberg ED Kwon, Current protocols in immunology, John E Coligan, et al, 2001 Chapter 20 Unit 20 25
41. Differential inductive signaling of prostate tumor-associated stromal cells compared to normal tissue stromal mesenchyme cells. LE Pascal J Ai RZN Vncio EF Vncio Y Zhou LS Page LD True Z Wang AY Liu, Cancer Microenvironment 2011 4 1 51 59 10.1007/s12307-010-0061-4 21505567
42. PC3 human prostate carcinoma cell holoclones contain self-renewing tumor-initiating cells. H Li X Chen T Calhoun-Davis K Claypool DG Tang, Cancer Res 2008 68 6 1820 1825 10.1158/0008-5472.CAN-07-5878 18339862 (Pubitemid 351416567)
43. Cancer stem-like cells in human prostate carcinoma cells DU145: the seeds of the cell line? C Wei W Guomin L Yujun Q Ruizhe, Cancer Biology & Therapy 2007 6 5 763 768 10.4161/cbt.6.5.3996 21611205 (Pubitemid 47328359)
44. Androgen deprivation and stem cell markers in prostate cancers. Y Tang AW Hamburger L Wang MA Khan A Hussain, International Journal of Clinical and Experimental Pathology 2009 3 2 128 138 20126580
45. Basal and luminal breast cancers: basic or luminous? (review). D Birnbaum F Bertucci C Ginestier R Tagett J Jacquemier E Charafe-Jauffret, Int J Oncol 2004 25 2 249 258 15254720
46. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. AF Olumi GD Grossfeld SW Hayward PR Carroll TD Tlsty GR Cunha, Cancer Res 1999 59 19 5002 5011 10519415 (Pubitemid 29472907)
47. A novel M(r) 32,000 nuclear phosphoprotein is selectively expressed in cells competent for self-renewal. LD Walensky DS Coffey TH Chen TC Wu GR Pasternack, Cancer Res 1993 53 19 4720 4726 7691403 (Pubitemid 23304406)
48. Stem cells in epithelial tissues. JM Slack, Science 2000 287 5457 1431 1433 10.1126/science.287.5457.1431 10688782 (Pubitemid 30127127)
49. Identification and isolation of human prostate epithelial stem cells based on alpha(2)beta(1)-integrin expression. AT Collins FK Habib NJ Maitland DE Neal, Journal of Cell Science 2001 114 Pt 21 3865 3872 11719553 (Pubitemid 33094701)